These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4796692)

  • 1. A comparative study on the metabolism of human insulin and porcine proinsulin in man.
    Sönksen PH; Tompkins CV; Srivastava MC; Nabarro JD
    Clin Sci Mol Med; 1973 Nov; 45(5):633-54. PubMed ID: 4796692
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of the distribution and metabolism of monocomponent human insulin and porcine proinsulin in man.
    Tompkins CV; Srivastava MC; Sönksen PH; Nabarro JD
    Biochem J; 1971 Dec; 125(3):64P. PubMed ID: 5169438
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of biosynthetic human proinsulin on carbohydrate metabolism.
    Revers RR; Henry R; Schmeiser L; Kolterman O; Cohen R; Bergenstal R; Polonsky K; Jaspan J; Rubenstein A; Frank B
    Diabetes; 1984 Aug; 33(8):762-70. PubMed ID: 6378699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of insulin induced hypoglycaemia on the blood levels of catecholamines, glucagon, growth hormone, cortisol, C-peptide and proinsulin before and during medication with the cardioselective beta-receptor blocking agent metoprolol in man.
    Hökfelt B; Hansson BG; Heding LG; Nilsson KO
    Acta Endocrinol (Copenh); 1978 Mar; 87(3):659-67. PubMed ID: 343472
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of a two hour proinsulin infusion on the glucose lowering potency of a following insulin injection.
    Hübinger A; Randerath W; Tosetti P; Schlüter KJ; Gries FA
    Horm Metab Res Suppl; 1988; 18():34-7. PubMed ID: 3056809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of hormonal counterregulation during GCIIS-guided hypoglycemia tests using human proinsulin and human insulin (recombinant DNA).
    Müller-Esch G; von der Lühe C; Ball P; Henkel E; Schlüter KJ; Wood WG; Scriba PC
    Horm Metab Res Suppl; 1988; 18():24-33. PubMed ID: 2847967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of proinsulin, insulin, and C-peptide in the rat.
    Katz AI; Rubenstein AH
    J Clin Invest; 1973 May; 52(5):1113-21. PubMed ID: 4700486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of proinsulin pretreatment on the combined actions of insulin and proinsulin in normal man.
    Glauber HS; Wallace P; Galloway J; Frank BH; Olefsky JM
    J Clin Endocrinol Metab; 1986 Apr; 62(4):785-8. PubMed ID: 3512594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative dissimilarities of insulin and proinsulin binding and action in vitro at IM 9-lymphocytes.
    Rausch UW; Fussgänger RD; Heinze E
    Horm Metab Res Suppl; 1988; 18():89-92. PubMed ID: 3056819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of serum proinsulin-like material: cross-reactivity of porcine and human proinsulin in the insulin radioimmunoassay.
    Starr JI; Mako ME; Juhn D; Rubenstein AH
    J Lab Clin Med; 1978 Apr; 91(4):683-92. PubMed ID: 641392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects of intravenous proinsulin.
    Petersen KG; Storch M; Schuler G; Kerp L
    Horm Metab Res Suppl; 1988; 18():68-73. PubMed ID: 3056815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo deactivation of proinsulin action on glucose disposal and hepatic glucose production in normal man.
    Glauber HS; Revers RR; Henry R; Schmeiser L; Wallace P; Kolterman OG; Cohen RM; Rubenstein AH; Galloway JA; Frank BH
    Diabetes; 1986 Mar; 35(3):311-7. PubMed ID: 3512341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthetic human proinsulin, a new therapeutic compound for diabetics? A comparative study of biosynthetic human proinsulin with biosynthetic human insulin.
    Rosak C; Boehm BO; Althoff PH; Schöffling K
    Horm Metab Res Suppl; 1988; 18():16-21. PubMed ID: 3056807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the defect in pro-hormone processing in Type 2 diabetes mellitus restricted to the beta cell?
    Bano G; Rodin DA; White A; O'Rahilly S; Nussey SS
    Diabet Med; 2001 Jan; 18(1):17-21. PubMed ID: 11168336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hydrocortisone and corticotropin on glucose-induced insulin and proinsulin secretion in man.
    Kitabchi AE; Jones GM; Duckworth WC
    J Clin Endocrinol Metab; 1973 Jul; 37(1):79-84. PubMed ID: 4351776
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypoglycemia following insulin and proinsulin. A comparison.
    Petersen KG; Licht T; Storch M; Pilot PR; Alexopoulos A; Lehmann M; Weigel S; Kerp L
    Horm Metab Res; 1986 Aug; 18(8):530-4. PubMed ID: 3530932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of subcutaneous human proinsulin on the production of 64/65 split proinsulin, glucose turnover and intermediary metabolism in non-insulin-dependent diabetic man.
    Davis SN; Piatti PM; Monti L; Brown M; Hetherington C; Antsiferov M; Sobey W; Hales CN; Orskov H; Alberti KG
    Diabetes Res Clin Pract; 1993 Feb; 19(2):103-13. PubMed ID: 8472625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective suppression of hepatic glucose output by human proinsulin in the dog.
    Lavelle-Jones M; Scott MH; Kolterman O; Rubenstein AH; Olefsky JM; Moossa AR
    Am J Physiol; 1987 Feb; 252(2 Pt 1):E230-6. PubMed ID: 2881485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interactions of proinsulin with insulin receptors on the plasma membrane of the liver.
    Freychet P
    J Clin Invest; 1974 Nov; 54(5):1020-31. PubMed ID: 4421396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of exogenous bonito insulin on endogenous insulin secretion in dogs.
    Ohgawara H; Tasaka Y; Kosaka K; Shizume K
    Endocrinol Jpn; 1974 Apr; 21(2):147-56. PubMed ID: 4408208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.